US/UK/Canada

Share

Quotes

Musculoskeletal pain is a big health issue affecting quality of life for the vast majority of the population. As a health issue, it deserves more attention, and we have seen the need for more insights and knowledge. On the ThermaCare® website we will provide articles and interviews on this important subject, as well as information about ThermaCare as an effective and drug-free pain relief
Astrid T. Bratvedt
The addition of the antibiotics portfolio marked an important milestone for Navamedic and our expanding hospital and prescription drug offering. We are pleased to welcome Icepharma to join us in securing steady supply of these important products to Nordic hospitals,
says Kathrine Gamborg Andreassen, CEO of Navamedic.
Pick a time period -
Tags ( Active)

NAVAMEDIC ASA: Minutes of Extraordinary General Meeting

An Extraordinary General Meeting of Navamedic ASA (the "Company") was held today, on 5 August 2019, at the Company's offices in Oslo. The minutes from the Extraordinary General Meeting are attached hereto. The general meeting adopted all the proposals on the agenda, including the approval of the joint demerger plan dated 19 June 2019 for the demerger of the Company as the transferring company with Observe Medical ASA as the acquiring company. Subject to the satisfaction of the conditions precedent for the demerger, the demerger is expected to be completed and become effective in the

Navamedic is launching Alflorex in Norway

Oslo, 5th August 2019 – Navamedic ASA (OSE: NAVA) today announced the launch of Alflorex®, a unique product for irritable bowel syndrome (IBS), in Norway in September 2019. Navamedic also have the territory rights to launch Alflorex® in Denmark and Iceland.“We are pleased to announce that Navamedic is entering into the gastro therapeutic area through the first probiotic product with IBS as approved indication. Alflorex® for IBS is part of a strategic partnership with PrecisionBiotics Ltd., who is developing unique bacteria cultures that have been specifically researched and rigorously

Navamedic ASA: Releases SippLink™ for MetaVision, one of Europe’s leading electronic patient journal systems.

Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, announced today that it has released its wireless connectivity solution, SippLink™ for iMDsoft’s patient data monitoring system (PDMS), MetaVision. The release follows successful validation at Uppsala University Hospital in Sweden, and represents the market’s first wireless PDMS-connected digital urinometer.SippLink enables wireless transfer of data between the Sippi urine measuring system and an external patient data monitoring systems (PDMS). Following successful validation at the University Hospital of

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe